SEC Tracker
Get the app

BridgeBio Pharma BBIO

Frank McCormick, insider filing for BBIO (amended)

Form
4/A
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when BridgeBio Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  4. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  5. Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.